SPARFLOXACIN - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for sparfloxacin and what is the scope of patent protection?
Sparfloxacin
is the generic ingredient in one branded drug marketed by Mylan and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for SPARFLOXACIN
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 94 |
Clinical Trials: | 1 |
Patent Applications: | 5,977 |
Formulation / Manufacturing: | see details |
DailyMed Link: | SPARFLOXACIN at DailyMed |
Recent Clinical Trials for SPARFLOXACIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Louisville | Early Phase 1 |
James Graham Brown Cancer Center | Early Phase 1 |
Julio Ramirez | Early Phase 1 |
US Patents and Regulatory Information for SPARFLOXACIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan | ZAGAM | sparfloxacin | TABLET;ORAL | 020677-001 | Dec 19, 1996 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for SPARFLOXACIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Mylan | ZAGAM | sparfloxacin | TABLET;ORAL | 020677-001 | Dec 19, 1996 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |